抗菌薬感受性試験の世界市場規模、シェア、成長分析、試験タイプ別、エンドユーザー別、製品タイプ別-産業予測、2023～2030年

抗菌薬感受性試験の世界市場規模は、2022年に36億米ドルと評価され、予測期間（2024～2031年）のCAGRは5.20%で、2023年の37億9,000万米ドルから2031年までに56億8,000万米ドルに成長する展望です。

世界の抗菌薬感受性試験（AST）市場は、抗菌薬耐性の蔓延と効果的な治療戦略の必要性の高まりに後押しされ、顕著な成長を遂げています。ASTは、臨床医が適切な抗菌薬療法を選択し、最適な治療結果を確保し、薬剤耐性病原体の急増に対処する上で極めて重要な役割を果たしています。ASTの主要目的は、様々な抗生物質に対する微生物の感受性に関する正確でタイムリーな情報を提供することです。ASTは、医療専門家が抗生物質の選択、投与量、治療期間に関して十分な情報を得た上で意思決定できるようにし、感染症の効率的な管理に貢献します。最も効果的な抗生物質を特定することで、ASTは個別化された治療計画を促進し、治療失敗のリスクを軽減し、抗菌薬スチュワードシップの取り組みを支援します。抗菌薬感受性試験市場の成長を後押ししている主要要因はいくつかあります。罹患率、死亡率、医療コストの増加につながる抗菌薬耐性の負担の増大が、ASTの需要を促進しています。さらに、感染症アウトブレイクや院内感染の急増、標的治療の必要性に対する意識の高まりが、市場拡大の原動力となっています。迅速なAST手法の採用、自動化、ASTシステムへの分子診断の統合は、市場の成長をさらに刺激します。とはいえ、資源に制約のある環境では高度なAST法へのアクセスが限られていること、高度な試験技術の導入コストが高いこと、試験結果の解釈が複雑であること、試験法の標準化が困難であること、従来のAST法には時間がかかることなどの課題が、市場の成長を阻害する可能性があります。抗菌薬感受性試験市場の主要動向としては、迅速かつ高精度なASTシステムの市場開拓、データ解析のための人工知能（AI）と機械学習アルゴリズムの導入、複数の薬剤耐性パターンを同時に検出するためのマルチプレックス試験への注目の高まりなどが挙げられます。また、ポイントオブケア試験に対する需要の高まり、試験室における自動ASTシステムの採用、感染症管理における個別化医療の重視の高まりなど、同市場には成長とイノベーションの大きな機会も存在します。診断企業、研究機関、医療機関のコラボレーションは、AST技術の進歩を促進し、市場範囲を拡大すると予想されます。

目次

エグゼクティブサマリー

• 市場概要
• 転変

調査手法

• 情報調達
• セカンダリとプライマリデータソース
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主要投資の分析
• 主要成功要因
• 競合の程度

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

抗菌薬感受性試験の世界市場：試験タイプ別

• 市場概要
• 表現型試験
• 遺伝子型試験
• 迅速試験

抗菌薬感受性試験の世界市場：エンドユーザー別

• 市場概要
• 病院と診断ラボ
• 研究と学術機関
• 製薬企業やバイオテクノロジー企業

抗菌薬感受性試験の世界市場：製品タイプ別

• 市場概要
• 機器
• 試薬とキット
• ソフトウェアとサービス

抗菌薬感受性試験の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主要市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（米国）
• Bio-Rad Laboratories, Inc.（米国）
• Danaher Corporation（米国）
• Becton, Dickinson and Company（米国）
• bioMerieux SA（フランス）
• Roche Diagnostics（スイス）
• Abbott Laboratories（米国）
• Bruker Corporation（米国）
• Merck KGaA（ドイツ）
• Agilent Technologies, Inc.（米国）
• ConvaTec Group plc（英国）
• Cepheid（米国）
• HiMedia Laboratories Pvt. Ltd.（インド）
• Liofilchem s.r.l.（イタリア）
• Accelerate Diagnostics, Inc.（米国）
• Creative Diagnostics（米国）
• Bio-Rad Laboratories（米国）
• Synbiosis（英国）
• ELITechGroup（フランス）
• QIAGEN N.V.（ドイツ）

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.60 Billion in 2022 and is poised to grow from USD 3.79 Billion in 2023 to USD 5.68 Billion by 2031, at a CAGR of 5.20% during the forecast period (2024-2031).

The global Antimicrobial Susceptibility Testing (AST) Market is experiencing notable growth, fueled by the rising prevalence of antimicrobial resistance and the imperative for effective treatment strategies. AST plays a pivotal role in assisting clinicians in choosing appropriate antimicrobial therapies, ensuring optimal treatment outcomes, and addressing the surge of drug-resistant pathogens. Its primary objective is to furnish accurate and timely information on microorganisms' susceptibility to various antibiotics. AST empowers healthcare professionals to make informed decisions regarding antibiotic selection, dosage, and treatment duration, contributing to the proficient management of infectious diseases. By identifying the most effective antibiotics, AST facilitates personalized treatment plans, mitigates the risk of treatment failure, and supports antimicrobial stewardship initiatives. Several key factors are propelling the growth of the antimicrobial susceptibility testing market. The escalating burden of antimicrobial resistance, leading to increased morbidity, mortality, and healthcare costs, propels the demand for AST. Furthermore, the upsurge in infectious disease outbreaks, hospital-acquired infections, and heightened awareness of the necessity for targeted therapies drive market expansion. The introduction of rapid AST methods, automation, and the integration of molecular diagnostics into AST systems further stimulate market growth. Nevertheless, challenges such as limited access to advanced AST methods in resource-constrained settings, high implementation costs for sophisticated testing technologies, the intricacy of interpreting test results, difficulties in standardizing testing methods, and the time-consuming nature of traditional AST methods may impede market growth. Key trends in the antimicrobial susceptibility testing market involve the development of rapid and precise AST systems, the incorporation of artificial intelligence (AI) and machine learning algorithms for data analysis, and an increased focus on multiplex testing to detect multiple drug resistance patterns simultaneously. The market also presents substantial opportunities for growth and innovation, including the rising demand for point-of-care testing, the adoption of automated AST systems in laboratories, and the growing emphasis on personalized medicine in infectious disease management. Collaborations between diagnostic companies, research institutions, and healthcare organizations are anticipated to drive advancements in AST technologies and expand market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Susceptibility Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Susceptibility Testing Market Segmental Analysis

Global Antimicrobial Susceptibility Testing Market is segmented on the basis of test type, end user, product type, and region. By test type, the market is segmented into phenotypic testing, genotypic testing, and rapid testing. By end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. By product type, the market is segmented into Instruments, reagents and kits, and software and services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Antimicrobial Susceptibility Testing Market

The surge in antimicrobial resistance stands out as a major catalyst for the Antimicrobial Susceptibility Testing (AST) market. The advent of drug-resistant pathogens poses a grave and widespread threat to public health. A noteworthy example is the escalating prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections, underscoring the critical necessity for precise AST. This need arises to guide clinicians in making informed decisions regarding the selection of suitable antibiotics for effective treatment.

Restraints in the Global Antimicrobial Susceptibility Testing Market

Limited access to advanced Antimicrobial Susceptibility Testing (AST) technologies in resource-constrained settings poses a hindrance to market growth. For instance, low-income countries may encounter difficulties in adopting automated AST systems due to their elevated costs and the requirement for adequately trained personnel.

Market Trends of the Global Antimicrobial Susceptibility Testing Market

The incorporation of artificial intelligence (AI) and machine learning algorithms for analyzing Antimicrobial Susceptibility Testing (AST) data is an expanding trend. These technologies play a crucial role in deciphering intricate datasets, enhancing the precision, and expediting the interpretation of AST results. An illustrative instance is the AI-powered platform DeepAMR, which utilizes machine learning to forecast bacterial susceptibility to antibiotics by leveraging genomic data.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Antimicrobial Susceptibility Testing Market by Test type

• Market Overview
• Phenotypic testing
• genotypic testing
• and rapid testing

Global Antimicrobial Susceptibility Testing Market by End user

• Market Overview
• Hospitals and diagnostic laboratories
• research and academic institutes
• and pharmaceutical and biotechnology companies

Global Antimicrobial Susceptibility Testing Market by Product type

• Market Overview
• Instruments
• reagents and kits
• and software and services

Global Antimicrobial Susceptibility Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConvaTec Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiosis (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELITechGroup (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments